Prevalence of overuse of short-acting beta-2 agonists (SABA) and associated factors among patients with asthma in Germany | Respiratory Research | Full Text
Beta2-Agonists for Asthma: Uses, Side Effects, Dosages
Long-Acting Beta-Adrenoceptor Agonist - an overview | ScienceDirect Topics
Asthma-Related Health Outcomes Associated with Short-Acting β2-Agonist Inhaler Use: An Observational UK Study as Part of the SABINA Global Program | Advances in Therapy
Short-acting β2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study | European Respiratory Society
Prevalence of overuse of short-acting beta-2 agonists (SABA) and associated factors among patients with asthma in Germany | Respiratory Research | Full Text
Prevalence of overuse of short-acting beta-2 agonists (SABA) and associated factors among patients with asthma in Germany - GAA Interasma
Landscape of short‐acting beta‐agonists (SABA) overuse in Europe - Vecillas - 2023 - Clinical & Experimental Allergy - Wiley Online Library
SABA Medications for Asthma: Benefits, Side Effects, and More
Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme | European Respiratory Society
Drugs affecting the respiratory system. Main disorders of the respiratory system are 1.Bronchial asthma. 2.Chronic obstructive pulmonary disease (COPD). - ppt download
Short-acting beta agonist (SABA) medication use overall and by SABA... | Download Scientific Diagram
Understanding relationships between asthma medication use and outcomes in a SABINA primary care database study | npj Primary Care Respiratory Medicine
Reducing short-acting beta-agonist overprescribing in asthma: lessons from a quality-improvement prescribing project in East London | British Journal of General Practice